| A19 | In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of residual viremia and rebound viruses | E-poster | Characterizing HIV/SIV reservoirs and rebounding virus |
| A19 | Proviral turnover pre-ART is dynamic and variable between hosts, impacting reservoir composition | E-poster | Characterizing HIV/SIV reservoirs and rebounding virus |
| A19 | Subtype D HIV-1 reservoir levels and viral sequence profiles in Rakai, Uganda | E-poster | Characterizing HIV/SIV reservoirs and rebounding virus |
| A19 | Translation-competent expanded HIV clones are phenotypically diverse | E-poster | Characterizing HIV/SIV reservoirs and rebounding virus |
| A20 | XPB degradation by Spironolactone prevents HIV-1 reactivation from latency | E-poster | Eliminating and silencing latency |
| A20 | Dasatinib inhibits provirus reactivation in patients co-infected with HIV and HCV | E-poster | Eliminating and silencing latency |
| A23 | Novel vector systems towards a cure for HIV/AIDS | E-poster | Gene therapy |
| A23 | Using the CRISPR-Cas9 system to cure cells from HIV and at the same time prevent super-infection by new HIV strains | E-poster | Gene therapy |
| A23 | Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a and b systems | E-poster | Gene therapy |
| A23 | A novel design algorithm to predict the silencing activity of siRNA | E-poster | Gene therapy |